Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Acute Treatment
.
Show all posts
Showing posts with label
Acute Treatment
.
Show all posts
Thursday, November 13, 2025
FDA Approves Brekiya (dihydroergotamine mesylate) Injection for the Acute Treatment of Migraine and Cluster Headaches in Adults
›
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) announced the U.S. Food and Drug Administration (FDA) approval of ...
Monday, June 30, 2025
FDA Approves Symbravo (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults
›
Axsome Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has approval of Symbravo (meloxicam and rizatripta...
Thursday, June 12, 2025
FDA Approves Atzumi (dihydroergotamine) Nasal Powder for the Acute Treatment of Migraine
›
Shin Nippon Biomedical Laboratories, Ltd. (TSE:2395), announced the U.S. Food and Drug Administration (FDA) approval of New Drug Applic...
›
Home
View web version
